A new study from Bradley Hospital and The Warren Alpert Medical School of Brown University, as well as two other institutions, adds to mounting evidence that clinicians consider irritability as a symptom when diagnosing pediatric bipolar disorder.

Reporting in the July issue of the Journal of the American Academy of Child and Adolescent Psychiatry, researchers say a small percentage of children with bipolar disorder experience manic episodes without extreme elation one of the hallmarks of the disorder and are diagnosed based on irritable mood alone.

“Diagnosing children with bipolar disorder is challenging. One of the chief controversies is whether irritability should be included among the criteria for this diagnosis because it can also overlap with a number of other psychiatric disorders, such as attention deficit hyperactivity disorder,” says lead author Jeffrey Hunt, MD, a child psychiatrist and training director at Bradley Hospital. “Our findings confirm that while irritableonly mania is uncommon, it does exist particularly in younger children and should be considered in a bipolar diagnosis.”

Bipolar disorder is characterized by dramatic mood swings from euphoria, elation and irritability the manic phase of the disorder to severe depression. Bipolar disorder often begins in late adolescence or early adulthood, although it can develop as early as the preschool years. Recent studies have shown that the number of children and teens being treated for bipolar disorder has grown dramatically in the last decade. Although it is unclear what has caused this increase, experts believe it may be due in part to more aggressive diagnoses by physicians and a greater awareness of pediatric bipolar disorder in the medical community.

Hunt and colleagues studied 361 children between the ages of 7 and 17 with bipolar disorder participating in the multisite Course and Outcome of Bipolar Illness in Youth (COBY) study at Bradley Hospital and Alpert Medical School, the University of Pittsburgh and the University of CaliforniaLos Angeles. COBY is the largest and most comprehensive study of children and adolescents with bipolar disorder to date.

Researchers quantified the frequency and severity of manic symptoms of each participant, including whether irritability and elation were present. Based on this data, the group was then reclassified into three subgroups elationonly, irritableonly and both elated and irritable.

Approximately 10 percent of children fell into the irritableonly category, while elatedonly constituted about 15 percent. Nearly threequarters experienced both elation and irritability. The irritableonly participants were significantly younger in age than the other two groups; however, there were no other sociodemographic differences between the groups. There were also no significant differences in terms of bipolar subtype, rate of psychiatric comorbidities, severity and duration of illness, and family history of mania and other psychiatric disorders. However, depression and alcohol abuse in seconddegree relatives occurred more frequently in the irritableonly subgroup.

“The fact that the irritableonly and elationonly subgroup had similar clinical characteristics and family histories of bipolar disorder provides support for continuing to consider episodic irritability in the diagnosis of pediatric bipolar disorder,” says Hunt, who is an assistant professor of psychiatry and human behavior at Alpert Medical School. Hunt is also training director of the child and adolescent fellowship and triple board residency programs.

The authors say continual, longterm followup of this study sample will help clarify whether the presence or predominance of elation or irritability at baseline will predict future clinical outcomes.

The research was funded by a grant from the National Institute of Mental Health. Study coauthors include Jennifer Dyl and the late Henrietta Leonard from Bradley Hospital and Alpert Medical School; Christianne EspositoSmythers, Martin Keller, Lance Swenson and Robert Stout from Alpert Medical School; Boris Birmaher, David Axelson, Neal Ryan, Benjamin Goldstein, Tina Goldstein, MaryKay Gill and Mei Yang from the University of Pittsburgh Medical Center; and Michael Strober from the David Geffen School of Medicine, University of California at Los Angeles.

Source
Jessica Collins Grimes

It is well known that chronic pain and clinical depression go together, but a study in The Journal of Pain, published by the American Pain Society, shows that the connection between pain and depression is strongest in middleage women and African Americans.

Researchers at Wayne State University studied a representative community sample of 1,100 Michigan residents and found that the incidence of chronic pain, defined as pain persisting for six months, was 22 percent. Approximately 35 percent of those with chronic pain said they had depression, but mood problems were not associated with a particular pain condition or pain site. Researchers evaluated several demographic factors and found that older age was generally related to chronic pain but with comorbid depression. They noted that depression tends to decrease with age while pain tends to increase.

From the data, the authors concluded that in middleage women chronic pain might not be the cause of depression but preexisting mood problems could be associated with development of chronic pain. They further concluded that depression can increase vulnerability to experiencing persistent pain.

The study also showed that African Americans were more likely to have chronic pain with depression than Caucasians. Further analysis showed that racial differences were not attributable to possible socioeconomic factors but might be associated with differences in the use of pain coping strategies. Though income was not a significant risk factor for the study, the authors indicated that occupational factors, such as physically demanding work and poor or no health insurance coverage, may account for the link between lower socioeconomic status and pain, and that financial strain and stress are closely linked with depression.

From their findings, the authors recommend that clinicians screen pain patients for depression and pay close attention to middleage women and African Americans for whom risk for comorbid depression is the highest.

Irritations of the bowel can have genetic causes. Researchers at the Institute of Human Genetics at Heidelberg University Hospital have discovered that correlation. The causes of what is known as irritable bowel syndrome (IBS), one of the maximum common disorders of the gastrointestinal tract, are considered unclear making diagnosis and treatment extremely difficult. The results from Heidelberg, which were published in the prestigious journal Human Molecular Genetics, improve the outlook for an effective medication against a disease that is frequently played down as a functional disorder.

In Germany, approximately five million common general public are affected by IBS, women about twice as ofttimes as men. But only about 20 percent of these persons even consult a physician. abounding patients suffer from constipation, others from severe diarrhea, or a combination of both. The illness affects the general condition and quality of life of these patients and ofttimes lasts for months or even years.

Modified receptors vanguard to overstimulation of the bowel

Serotonin plays an of note role in the complex processes in the digestive tract upright as it affects sleep, mood, and blood pressure. Various types of receptors are located in the intestine, to which serotonin attaches according to the lock and key principle and thus transmits cellular signals.

“We have determined that patients who suffer from irritable bowel syndrome with diarrhea occurrence a higher constancy of sanguine mutations “, explains Dr. Beate Niesler, who investigates the genetic causes of complex diseases with her team in the unit of Human Molecular Genetics (Director Prof. Gudrun Rappold) at the Heidelberg Institute of Human Genetics. These mutations appear to cause changes in the composition or fraction of receptors on the cell surface. “The signal transduction in the digestive tract may be disturbed and that may stop to overstimulation of the intestine. Resulting disturbances in fluid balance could explain the occurrence of diarrhea”, says Johannes Kapeller, a PhD student in the team.

Medication blocks serotonin receptors

The serotonin receptor blocker Alosetron is only approved in the US where it is effectively used in the treatment of women suffering from diarrheapredominant IBS, but can only be prescribed with strict limitations due to its side effects. Alosetron inhibits the serotonin receptors in the intestinal tract and thus slows the movement of the bowels.

“Currently, patients with irritable bowel syndrome are treated on a trial and error basis”, explains Dr. Beate Niesler. The Heidelberg picture could contribute to development and prescription of especial medications for undoubtful genetic mutations in patients.

Correlation with depression and pain

Research of the serotonin integral shows interesting correlations serotonin receptors are located on neural transduction pathways involved in pain perception and influence them which could explain why patients with irritable bowel syndrome oftentimes complain of severe pain although no pathological changes such as infections or tumors are present. It has further oldfangled noted that persons with modified receptors suffer more frequently from depression.

exposition adapted by Medical News Today from original press release.

References

J. Kapeller et al., First evidence for an association of a functional variant in the microRNA510 target haunt of the serotonin receptorstrain 3E gene with diarrhea predominant irritable bowel syndrome, Human Molecular Genetics, 2008, Vol.17, No.19, 29672977.

Contact
Dr. Beate Niesler, PhD
University of Heidelberg
Institute of Human Genetics
Im Neuenheimer Feld 366

Source Dr. Annette Tuffs
University Hospital Heidelberg

frequent of the aid parcels who racket traumatic brain injuries in Iraq and Afghanistan are at risk for runningterm robustness quandarys such as depression and dementia, but it is unknown how colossal those risks are, according to an Institute of Medicine report released Thursday, the AP/Minneapolis StarTribune reports (Neergaard, AP/Minneapolis StarTribune, 12/5). An estimated 5,500 military personnel have suffered from a brain injury, and brain injuries history for about 22% of all casualties in Iraq and Afghanistan (Carey, New York Times, 12/5). For the IOM report, researchers examined antecedent studies on TBI and commence that it can be linked to protractedterm fettle risks such as depression, Alzheimerstwin dementia, Parkinsonsresembling symptoms, seizures, aggressive routine, dizziness, amnesia and predicaments with social functioning (AP/Minneapolis StarTribune, 12/5).

The report recommended that the staff of Defense and ward of Veterans Affairs conduct further studies “to confirm reports of terribleterm or latent effects of exposure to blasts” to better understand and treat TBI (New York Times, 12/5). The report suggested that the departments conduct cognitive skills tests on both pre and postdeployment soldiers to compare the farreachingterm effects of brain injuries. In accession, now and again soldier exposed to a blast, regardless of its size, should be screened for TBI, the report recommended. IOM as well recommended that VA establish a registry of employ portions with TBI to identify stretchingterm risk factors that improve or worsen outcomes and compare them to troops with nonbrain injuries (AP/Minneapolis StarTribune, 12/5).

Brig. Gen. Loree Sutton, director of the Defense Centers of Excellence for Psychological fine feather and Traumatic Brain Injury, said there was “no daylight intervening the recommendations and bustles the territory of Defense has taken already” to better evaluate brain injuries (New York Times, 12/5). VA is considering the recommendations and has 60 days to decide whether the protractedterm complexion risks will be a presumed coupler to the military appropriateness of veterans who experienced brain injuries.

period creator George Rutherford of the University of CaliforniaSan Francisco said, “I dont gather we really knew how big a hole in scientific knowledge there is about blastinduced brain injuries” (AP/Minneapolis StarTribune, 12/5).

An abstract of the report is available on the web.

Reprinted with kind permission from kaisernetwork.org. You can view the entire Kaiser Daily fettle protocol Report, search the archives, or augury up for news letter delivery at kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily shape theory Report is published for kaisernetwork.org, a free maintenance of The Henry J. Kaiser offspring Foundation.

&imprint; 2008 Advisory Board ensemble and Kaiser kind Foundation. All rights secretive.

multiplied of the office segments who reality traumatic brain injuries in Iraq and Afghanistan are at risk for faroffterm form troubles such as depression and dementia, but it is unknown how lanky rise those risks are, according to an Institute of Medicine report released Thursday, the AP/Minneapolis StarTribune reports (Neergaard, AP/Minneapolis StarTribune, 12/5). An estimated 5,500 military personnel have suffered from a brain injury, and brain injuries version for about 22% of all casualties in Iraq and Afghanistan (Carey, New York Times, 12/5). For the IOM report, researchers examined gone by studies on TBI and set up that it can be linked to lankyterm energy risks such as depression, Alzheimerscomparable dementia, Parkinsonsresembling symptoms, seizures, aggressive address, dizziness, amnesia and squeezes with social functioning (AP/Minneapolis StarTribune, 12/5).

The report recommended that the circuit of Defense and range of Veterans Affairs conduct further studies “to confirm reports of sustainedterm or latent effects of exposure to blasts” to better understand and treat TBI (New York Times, 12/5). The report suggested that the departments conduct cognitive skills tests on both pre and postdeployment soldiers to compare the lankyterm effects of brain injuries. In adding, ever and anon soldier exposed to a blast, regardless of its size, should be screened for TBI, the report recommended. IOM too recommended that VA establish a registry of applicability posts with TBI to identify sustainedterm risk factors that improve or worsen outcomes and compare them to troops with nonbrain injuries (AP/Minneapolis StarTribune, 12/5).

Brig. Gen. Loree Sutton, director of the Defense Centers of Excellence for Psychological wellbeing and Traumatic Brain Injury, said there was “no daylight separating the recommendations and ball fearlesss the ward of Defense has taken already” to better evaluate brain injuries (New York Times, 12/5). VA is considering the recommendations and has 60 days to decide whether the remoteterm euphoria risks will be a presumed ligation to the military overhaul of veterans who experienced brain injuries.

first deposit journalist George Rutherford of the University of CaliforniaSan Francisco said, “I dont project we really knew how big a hole in scientific knowledge there is about blastinduced brain injuries” (AP/Minneapolis StarTribune, 12/5).

An abstract of the report is available on the internet.

Reprinted with kind permission from kaisernetwork.org. You can view the entire Kaiser Daily good condition approach Report, search the archives, or portent up for e postcard delivery at kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily fine feather practice Report is published for kaisernetwork.org, a free supply of The Henry J. Kaiser blood Foundation.

&offprint; 2008 Advisory Board muster and Kaiser relations Foundation. All rights retiring.

A new universal fling to predict the risk of someone succumbing to major depression has anachronistic developed by UCL (University College London) researchers. The on the internet gadget, predictD, could eventually be used by blood doctors and vernacular clinics to identify those at risk of depression for whom prevention might be maximum useful.

The risk algorithm, developed by a team led by UCL Professors Michael King and Irwin Nazareth, was tested in 6,000 community visiting their folk doctor in six countries in Europe (UK, Spain, Portugal, the Netherlands, Slovenia and Estonia). Its accuracy was further tested in nearly 3,000 GP attendees in a further country, Chile, in South America. The study, published in the Archives of General Psychiatry, followedup the participants at six and 12 months. The team modelled their approach on risk indices for heart disease, which provide a percentage risk estimate concluded a liable inferior period. The algorithm was as accurate at predicting future episodes of depression as similar instruments developed in Europe to predict future risk of heart disagreements.

A website has superannuated set up for the risk algorithm, at ucl.ac.uk/predictdepression

Further eliminating of the dojigger as an early detector of depression is planned in randomised trials of prevention in Europe. The team are too exploring the feasibility of using the instrument in China, with plans to set up a study on the prediction of depression in a Chinese community distance. that would be the first ever research initiative of its kind within Asia.

Professor Michael King, UCL constituency of Mental fitness Sciences, says “Depression is a common problem everywhere the universe, but although we fathom how to treat it, we comprehend very little about how to prevent its onset. We have ways of predicting the onset of heart disease or stroke, but none for predicting inhabitantss risk of major depression. Our study is one of the first to foster a risk algorithm for dispassionate that purpose.”

“Risk tools such as ours are needed to sweat more effort on preventing depression. For for instance, persons identified as at risk by an on the web machine could be flagged on a GPs computer. Recognition of those at risk could sustenance with watchful waiting or active support, such as restarting treatment in patients with a history of depression. Patients could including be advised on the nature of depression or on cognitive behaviour therapies to corrective reduce their risk of developing major depression.”

“Major depression is now a leading cause of illness and disability spherewide and reducing its prevalence is one of the greatest public healthfulness challenges of the twentyfirst century. Depression will situation extra to cardiovascular disease as a global cause of disability by 2020. Up to a quarter of public who explore their doctor empiricism major depression, with relapses frequently occurring for up to 10 years.”

“The next stage of our research will be to establish how GPs could use our implement to succor prevent the onset of depression. We are hoping to run a exorbitantscale trial to explore the jobs use in prevention.”

Notes

1. Development and validation of an ecumenical risk prediction algorithm for episodes of major depression in general practice attendees, by Michael King et al., is published in the December issue of the Archives of General Psychiatry at archpsyc.amaassn.org Copies of the paper can more be obtained from the UCL Media Relations Office.

A new universal trial to predict the risk of someone succumbing to major depression has oldfashioned developed by UCL (University College London) researchers. The on the internet apparatus, predictD, could eventually be used by ancestors doctors and legendary clinics to identify those at risk of depression for whom prevention might be utmost useful.

The risk algorithm, developed by a team led by UCL Professors Michael King and Irwin Nazareth, was tested in 6,000 common masses visiting their brethren doctor in six countries in Europe (UK, Spain, Portugal, the Netherlands, Slovenia and Estonia). Its accuracy was too tested in nearly 3,000 GP attendees in a further country, Chile, in South America. The study, published in the Archives of General Psychiatry, followedup the participants at six and 12 months. The team modelled their approach on risk indices for heart disease, which provide a percentage risk estimate by a prone instant period. The algorithm was as accurate at predicting future episodes of depression as similar instruments developed in Europe to predict future risk of heart nuts.

A website has extinct set up for the risk algorithm, at ucl.ac.uk/predictdepression

Further finalizing of the bucksaw as an early detector of depression is planned in randomised trials of prevention in Europe. The team are and exploring the feasibility of using the instrument in China, with plans to set up a study on the prediction of depression in a Chinese community set. that would be the first ever research initiative of its kind within Asia.

Professor Michael King, UCL quarter of Mental robustness Sciences, says “Depression is a common problem completely the heavenly body, but although we be versed how to treat it, we be learned very little about how to prevent its onset. We have ways of predicting the onset of heart disease or stroke, but none for predicting human races risk of major depression. Our study is one of the first to grow up a risk algorithm for uncolored that purpose.”

“Risk tools such as ours are needed to concentrate more effort on preventing depression. For exemplar, inhabitants identified as at risk by an on the internet machine could be flagged on a GPs computer. Recognition of those at risk could guidance with watchful waiting or active support, such as restarting treatment in patients with a history of depression. Patients could furthermore be advised on the nature of depression or on cognitive behaviour therapies to cure reduce their risk of developing major depression.”

“Major depression is now a leading cause of illness and disability naturewide and reducing its prevalence is one of the greatest public tone challenges of the twentyfirst century. Depression will grade next to cardiovascular disease as a global cause of disability by 2020. Up to a quarter of folks who browse their doctor empiricism major depression, with relapses frequently occurring for up to 10 years.”

“The next stage of our research will be to establish how GPs could use our whatchamacallit to benefit prevent the onset of depression. We are hoping to run a exorbitantscale trial to explore the gadgets use in prevention.”

Notes

1. Development and validation of an terrene risk prediction algorithm for episodes of major depression in general practice attendees, by Michael King et al., is published in the December issue of the Archives of General Psychiatry at archpsyc.amaassn.org Copies of the paper can further be obtained from the UCL Media Relations Office.

IMPAX Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) granted final approval of the coteries Abbreviated New Drug Application (ANDA) for a generic version of Wellbutrin® XL 150 mg Extendedrelease Tablets on Wednesday, November 26, 2008. GlaxoSmithKline drugstores Wellbutrin® XL for the management of depression. IMPAXs Global Pharmaceuticals division launched the product immediately following approval.

According to Wolters Kluwer good condition, U.S. sales of Wellbutrin® XL 150 mg tablets were approximately $950 million in the 12 months ended September 2008.

About IMPAX Laboratories, Inc.

IMPAX Laboratories, Inc. is a technology based specialty pharmaceutical team applying its formulation expertise and drug delivery technology to the development of controlledrelease and specialty generics in adding to the development of branded stock. IMPAX showrooms its generic concoctions through its Global Pharmaceuticals division and departments store its branded concoctions through the IMPAX Pharmaceuticals division. Additionally, where strategically appropriate, IMPAX has developed vending partnerships to fully leverage its technology platform. IMPAX Laboratories is headquartered in Hayward, California, and has a full range of capabilities in its Hayward and Philadelphia facilities. For more info, please see the clubs Web slot at impaxlabs.com.

“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995

To advice raise awareness about discrimination against inhabitants with mental illness, the Wyoming agency of hardiness is inviting residents with relevant personal actuality to participate in a December 3 public hearing in Cheyenne.

“We appetite society who have encountered discrimination as of mental illness to share their personal stories and describe the impact on themselves and their families,” said Rodger McDaniel, Wyoming arena of vigor deputy director for mental bloom and substance abuse services.

A “listening panel” with hoveringplane representatives of various state agencies will participate and a formal record of the proceedings is planned.

“Consumers should distinguish their testimony matters,” McDaniel said. “In augmentation to counting awareness of mental robustnessinterwoven discrimination, we surmise to use the network we gather to enroot a plan our branch can use to balm address the issue.”

The meeting is scheduled for 1 to 4 p.m. in the Cottonwood Room of the Laramie County Library (2200 Pioneer Avenue) in Cheyenne.

The hearing is being cosponsored by the Wyoming commission of fine feathers Mental energy and Substance Abuse Services Division, UPLIFT and the Wyoming Citizen Review Panel. For more confidence, contact Felicia Gutierrez at 3077773357.

Wyoming office of Health

To comfort raise awareness about discrimination against community with mental illness, the Wyoming beat of bloom is inviting residents with relevant personal doing to participate in a December 3 public hearing in Cheyenne.

“We appetite community who have encountered discrimination whereas of mental illness to share their personal stories and describe the impact on themselves and their families,” said Rodger McDaniel, Wyoming subdivision of salubrity deputy director for mental fine feather and substance abuse services.

A “listening panel” with altitudinousparallel representatives of various state agencies will participate and a formal record of the proceedings is planned.

“Consumers should learn their testimony matters,” McDaniel said. “In extension to summing awareness of mental wholenessinterconnected discrimination, we suspect to use the orientation we gather to promote a plan our agency can use to cure address the issue.”

The meeting is scheduled for 1 to 4 p.m. in the Cottonwood Room of the Laramie County Library (2200 Pioneer Avenue) in Cheyenne.

The hearing is being cosponsored by the Wyoming unit of pinks Mental fettle and Substance Abuse Services Division, UPLIFT and the Wyoming Citizen Review Panel. For more clue, contact Felicia Gutierrez at 3077773357.

Wyoming range of Health